Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society

John L. Sapp; Wael Alqarawi; Ciorsti J. MacIntyre; Rafik Tadros; Christian Steinberg; Jason D. Roberts; Zachary Laksman; Jeff S. Healey; Andrew D. Krahn

doi:10.1016/j.cjca.2020.04.003

Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society

John L. Sapp, Wael Alqarawi, Ciorsti J. MacIntyre, Rafik Tadros, Christian Steinberg, Jason D. Roberts, Zachary Laksman, Jeff S. Healey, Andrew D. Krahn

Research output: Contribution to journal › Article › peer-review

95 Citations (Scopus)

Original language	English
Pages (from-to)	948-951
Number of pages	4
Journal	Canadian Journal of Cardiology
Volume	36
Issue number	6
DOIs	https://doi.org/10.1016/j.cjca.2020.04.003
Publication status	Published - Jun 2020
Externally published	Yes

ASJC Scopus Subject Areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.cjca.2020.04.003

Cite this

Sapp, J. L., Alqarawi, W., MacIntyre, C. J., Tadros, R., Steinberg, C., Roberts, J. D., Laksman, Z., Healey, J. S., & Krahn, A. D. (2020). Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society. Canadian Journal of Cardiology, 36(6), 948-951. https://doi.org/10.1016/j.cjca.2020.04.003

Sapp, JL, Alqarawi, W, MacIntyre, CJ, Tadros, R, Steinberg, C, Roberts, JD, Laksman, Z, Healey, JS & Krahn, AD 2020, 'Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society', Canadian Journal of Cardiology, vol. 36, no. 6, pp. 948-951. https://doi.org/10.1016/j.cjca.2020.04.003

@article{cde45ea5eb2e4ccb8cd929ac176d94c8,

title = "Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society",

author = "Sapp, {John L.} and Wael Alqarawi and MacIntyre, {Ciorsti J.} and Rafik Tadros and Christian Steinberg and Roberts, {Jason D.} and Zachary Laksman and Healey, {Jeff S.} and Krahn, {Andrew D.}",

note = "Publisher Copyright: {\textcopyright} 2020 Canadian Cardiovascular Society",

year = "2020",

month = jun,

doi = "10.1016/j.cjca.2020.04.003",

language = "English",

volume = "36",

pages = "948--951",

journal = "Canadian Journal of Cardiology",

issn = "0828-282X",

publisher = "Pulsus Group Inc.",

number = "6",

}

TY - JOUR

T1 - Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19

T2 - A Statement from the Canadian Heart Rhythm Society

AU - Sapp, John L.

AU - Alqarawi, Wael

AU - MacIntyre, Ciorsti J.

AU - Tadros, Rafik

AU - Steinberg, Christian

AU - Roberts, Jason D.

AU - Laksman, Zachary

AU - Healey, Jeff S.

AU - Krahn, Andrew D.

PY - 2020/6

Y1 - 2020/6

UR - http://www.scopus.com/inward/record.url?scp=85083831057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083831057&partnerID=8YFLogxK

U2 - 10.1016/j.cjca.2020.04.003

DO - 10.1016/j.cjca.2020.04.003

M3 - Article

C2 - 32299753

AN - SCOPUS:85083831057

SN - 0828-282X

VL - 36

SP - 948

EP - 951

JO - Canadian Journal of Cardiology

JF - Canadian Journal of Cardiology

IS - 6

ER -

Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this